Skip to main content
Program
#AHA25
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Journeys
AHA24
Advances in lipid therapeutics
Small-interfering RNA reduced Lp(a) levels, an oral disruptor of Lp(a) synthesis in the liver and selective cholesteryl ester transfer protein.
New approaches to managing AFib
Medical therapy for heart failure
Innovation in prevention
Save the date for #AHA25 in New Orleans
Managing patients with symptomatic mitral or tricuspid regurgitation
Discussion explores the role M-TEER and T-TEER play.
Environmental crises call for more CV research
Pollution, rising temperatures can have a big impact on health.
Sponsored
Lp(a) and Peripheral Artery Disease Toolkit
This toolkit raises awareness of Lp(a), why it is important to measure in addition to LDL, how Lp(a) intersects with PAD and more.
Streamlining the pathway to publish cardiovascular research
Starting in 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Paul Dudley White Lecture lays groundwork for promising patient outcomes.
Coronary and valvular heart disease
Liberal or restrictive oxygenation, GLP-1 agonist therapy, edoxaban and spironolactone.
Improving patient outcomes for sudden cardiac arrest
Technology-enhanced prediction tools, public awareness and training are key.
Redefining arrhythmia treatment
Catheter ablation, OPTION and Brain-AF.
At the intersection of heart and brain
Celebrating a century of cardiovascular science
Intensive blood pressure control, tirzepatide and novel gene editing therapy.
Collaborating across the Atlantic on critical care cardiology
CCC specialists in Europe and the U.S. exchange ideas and best practices.
Early Career Investigator Showcase illuminates paths forward in research
Nurses drive programs, clinics to treat heart disease
What women want: Better cardiovascular health
Watch AHAtv
See AHAtv now
#AHA24 in photos
Welcome new 2024 American Heart Association Fellows
AHA selects six Distinguished Scientists for 2024
Q&A: Research Goes Red recognition
Challenged by rare cardiomyopathies
Aspirin's staying power
Saturday in the Simulation Zone
